Skip to main content

Table 3 Clinical status of patients

From: Could admission level of uric acid predict total diuretic dose in acute heart failure?

Variables

Unit/Type

hyperuricemia Group

(Mean ± SD)

(Frequency/Percentage)

normal uric acid Group

(Mean ± SD)

(Frequency/Percentage)

Total

(Mean ± SD)

(Frequency/Percentage)

P-value

Blood pressure

Systolic

121.37 ± 25.83

126.62 ± 24.47

122.47 ± 25.52

0.430

Diastolic

77.71 ± 17.15

82.48 ± 20.85

78.71 ± 17.98

Heart rate

Beats/min

82.65 ± 16.54

89.86 ± 17.73

84.18 ± 16.97

0.489

Body temperature

Celsius

36.09 ± 3.33

36.65 ± 0.48

36.21 ± 2.98

0.196

SpO2

Percent

91.65 ± 5.1

92.57 ± 3.7

91.84 ± 4.84

0.102

HF type

Ischemic

36/45.6

7/33.3

43/43

0.683

 

Non-ischemic

43/54.4

14/66.7

57/57

0.314

AHF type

ADHF

63/79.7

15/71.4

78/78

0.413

DNHF

16/20.3

6/28.6

22/22

HF stage

C

53/70.7

15/75

68/71.6

0.703

D

22/29.3

5/25

27/28.4

NYHA

III

36/45.6

9/42.9

45/45

0.992

IV

19/24.1

5/23.8

24/24

Dyspnea

-

72/91.1

16/76.2

88/88

0.061

Orthopnea

-

20/25.3

4/19

24/24

0.550

Paroxysmal nocturnal dyspnea

-

4/5.1

1/4.8

5/5

0.955

Chest pain

-

15/19

5/23.8

20/20

0.623

Fatigue

-

14/17.7

4/19

18/18

0.888

Tachycardia

-

12/15.2

2/9.5

14/14

0.506

Edema

-

50/50.6

5/23.8

45/45

0.028

GI tract symptoms

-

16/20.3

4/19

20/20

0.902

Ascites

-

10/12.7

0/0

10/10

0.086

Elevated JVP

-

11/13.9

1/4.8

12/12

0.251